Faculty:  Daniel Ouellette, MD, FCCP

Through a review of recent evidence-based data, this course presents up-to-date information about the infections and physiologic problems associated with the use of blood products and describes steps to limit those risks.

To take this course choose your format at the bottom of this page.

Continuing Medical Education for Physicians

Accreditation Statement

MEBN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Credits

MEBN designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

FDA Disclosure Statement

The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Accreditation Period

Original release date: March 23, 2006 Reviewed and Renewed: March 23, 2008 Expiration Date: March 23, 2009

Any questions regarding the accreditation of this CME activity should be directed to MEBN. (accreditation@mebn.net)

Continuing Education for Nurses
MEBN is an approved provider of continuing nursing education by the New Hampshire Nurses’ Association Commission on Continuing Education, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. MEBN recognizes that the accredited status refers only to our continuing nursing education activities and does not imply that the ANCC Commission on Accreditation approves or endorses these commercial products.

Contact Hours
MEBN designates this continuing education activity for up to 0.25 contact hour(s) of nursing continuing education credit.

Accreditation Period
Original release date: March 23, 2006
Reviewed and Renewed: March 23, 2008
Expiration Date: March 23, 2009

Disclaimer
This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.

Supported by an educational grant from: